Showing 1 - 10 of 388
We examine the bipartite graphs of German corporate boards in 1993, 1999 and 2005, and identify cores of directors who are highly central in the entire network while being densely connected among themselves. Germany's corporate governance has experienced significant changes during this time, and...
Persistent link: https://www.econbiz.de/10010299742
We examine the bipartite graphs of German corporate boards in 1993, 1999 and 2005, and identify cores of directors who are highly central in the entire network while being densely connected among themselves. The novel feature of this paper is the focus on the dynamics of these networks....
Persistent link: https://www.econbiz.de/10010328875
We examine the bipartite graphs of German corporate boards in 1993, 1999 and 2005, and identify cores of directors who are highly central in the entire network while being densely connected among themselves. Germany’s corporate governance has experienced significant changes during this time,...
Persistent link: https://www.econbiz.de/10003906920
Persistent link: https://www.econbiz.de/10010229892
We examine the bipartite graphs of German corporate boards in 1993, 1999 and 2005, and identify cores of directors who are highly central in the entire network while being densely connected among themselves. Germany's corporate governance has experienced significant changes during this time, and...
Persistent link: https://www.econbiz.de/10008567506
This paper uses German household data on apparel purchases to show that, conditional on income, households differ with respect to their shopping outlets and the prices they pay. We estimate that high-price retailers are not affected by changes in import prices. By contrast, the pass-through for...
Persistent link: https://www.econbiz.de/10010954323
This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems - coinsurance and indemnity insurance - are compared with respect to changes in copayments and public health...
Persistent link: https://www.econbiz.de/10010954334
This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...
Persistent link: https://www.econbiz.de/10010954359
This paper studies externalities of nationally determined cost-sharing systems, in particular coinsurance rates (patients pay a percentage of the price), under pharmaceutical parallel trade in a two-country model with a vertical distributor relationship. Parallel trade generates a...
Persistent link: https://www.econbiz.de/10010954402
This paper studies the effect of two regulatory instruments - a price cap and a reference price system - a mandatory substitution rule, and the combination of both on generic competition in a Salop-type model with an off-patent brand-name drug and n differentiated generic versions. The price cap...
Persistent link: https://www.econbiz.de/10011268196